Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers.
Frank
Rolf Dario
RD
Altenwerth
Björn
B
Brandenburg
Vincent M
VM
Nolden-Koch
Martina
M
Block
Frank
F
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D001780:Blood Coagulation Tests; D005169:Factor VIII / Q000096:biosynthesis; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy; D011241:Prednisone / Q000494:pharmacology; D012307:Risk Factors; D013923:Thromboembolism; D013997:Time Factors; D014841:von Willebrand Factor / Q000096:biosynthesis
D000893:Anti-Inflammatory Agents; D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D005169:Factor VIII; D005340:Fibrinogen; D011241:Prednisone; D008775:Methylprednisolone